anti-parkinson's research

L-DOPA (Levodopa) is an orally active metabolic precursor of the neurotransmitter dopamine. It can cross the blood-brain barrier and be converted into dopamine in the brain. L-DOPA exhibits anti-hyperalgesic effects and holds potential in Parkinson’s disease research, and it can also be used to induce Parkinson’s disease models.

Safranal is the special volatile aroma compound of saffron

Evernic acid is a natural metabolite discovered in Evernia prunastri. It can cross the blood-brain barrier, inhibit TrxR1 enzyme activity and the NF-κB pathway, and exhibits neuroprotective and anti-inflammatory effects in Parkinson's disease models. It also possesses anticancer, antifungal, and antibacterial properties.

Isoquercetin (Standard) is a reference standard for research and analysis in studies involving Isoquercetin. 1. Isoquercetin (3-Glucosylquercetin) is a potential stimulator of bone mineralization used for prophylaxis of osteoporotic disorders. 2. Isoquercetin may be as a potential therapeutic agent against neurodegeneration in Parkinson's disease. 3. Isoquercetin is an inhibitor of Wnt/β-catenin and may be as a potential novel anti-tumoral agent, such as against human pancreati,liver cancer related to opioid receptors and to the activation of the mitogen-activated protein kinase (MAPK) signalling pathway. .

Ginkgetin (Standard) is a reference standard for research and analysis in studies involving Ginkgetin. 1. Ginkgetin has anti-influenza virus and anti-fungal activities. 2. Ginkgetin has anti-inflammatory activity, can down-regulates COX-2 induction in vivo against skin inflammatory responses. 3. Ginkgetin is a good STAT3 inhibitor and may be a useful lead molecule for development of a therapeutic STAT3 inhibitor. 4. Ginkgetin induces apoptosis in PC-3 cells via activation of caspase 3 and inhibition of survival genes as a potent chemotherapeutic agent for prostate cancer treatment. 5. Ginkgetin has neuroprotective activity against neurological injury induced by MPTP occurs via regulating iron homeostasis, it may provide neuroprotective therapy for Parkinson's disease and iron metabolism disorder related diseases.

Curcumin monoglucoside is a flavonoid derivative with antioxidant, anti-apoptotic (Apoptosis), neuroprotective, and antibacterial properties. It can be utilized in research related to Parkinson's disease.